Ligandrol (LGD-4033): A Tracking Guide for a Potent Mass-Building SARM
A harm-reduction look at ligandrol, why its strength comes with strong hormonal suppression, and the monitoring that actually matters.
At a glance
- What it is
- Selective androgen receptor modulator
- Route
- Oral
- Frequency
- Once daily
- Typical cycle
- 8-10 weeks
- First effects
- 2-4 weeks
Best for
Ligandrol, developed as LGD-4033, is one of the more potent mass-building selective androgen receptor modulators (SARMs). It is favored for adding lean mass and strength, but that potency comes with correspondingly strong suppression of natural testosterone.
This is an educational tracking guide, not medical advice or a recommendation. Ligandrol is an unapproved research chemical; it is not FDA-approved for any use, and consumer products are commonly mislabeled.
What it is
- A non-steroidal compound that strongly activates the androgen receptor in muscle and bone
- Regarded as more potent, and more suppressive, than ostarine
- Not an approved medicine despite early-phase research interest
Typical protocol shape
- Taken orally, once daily, over a defined block of weeks
- Doses and durations commonly reported in research literature; this guide does not prescribe one
- Usually run with a recovery plan because suppression is expected
What to track daily
- Bodyweight and training loads
- Libido, mood, and energy, which often decline as suppression sets in
- Water retention or fullness
What to track weekly
- Strength progression on compound lifts
- Bodyweight and waist trend
- Sleep and general well-being
Bloodwork worth doing
- Total and free testosterone, LH, and FSH before, during, and after
- A liver panel (ALT, AST)
- A lipid panel, since HDL commonly drops
Realistic expectations
- Noticeable strength and lean mass for many users within a few weeks
- Strong suppression is the trade-off; recovery can take time
- Some early human data reported transient liver enzyme and lipid changes
Safety notes
Ligandrol reliably suppresses natural testosterone, lowers HDL, and can raise liver enzymes. Most users need to plan for post-cycle therapy and confirm recovery with bloodwork. Because the market is unregulated, mislabeling and contamination are real risks and a common source of unexpected effects. This is a research chemical, not an approved drug, and it should be treated as one.
Peptid AI is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.
Atlas entry
Ligandrol (LGD-4033) — half-life, route and cautions
1.3 d · Oral